Absci (ABSI) Total Liabilities (2020 - 2026)
Absci (ABSI) posted Total Liabilities of $23.6 million for Q1 2026, down 12.02% sequentially from $26.8 million in Q4 2025, and down 29.8% YoY from $33.7 million in Q1 2025.
Absci (ABSI) Total Liabilities (2020 - 2026) Analysis & Trends
Absci has reported Total Liabilities for 7 years, with the latest figure at $23.6 million in Q1 2026.
- Quarterly Total Liabilities fell 29.8% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (down 29.8% YoY) and the FY2025 annual result came in at $26.8 million, down 22.12% from the prior year.
- Total Liabilities declined to $23.6 million in Q1 2026 per ABSI's latest filing, from $26.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $55.0 million in Q1 2022 and troughed at $23.6 million in Q1 2026.
- A 5-year average of $38.4 million and a median of $36.5 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities slumped 77.21% in 2022, then advanced 7.28% in 2025.
- Over 5 years, Total Liabilities stood at $46.6 million in 2022, then retreated by 11.74% to $41.1 million in 2023, then dropped by 16.16% to $34.5 million in 2024, then decreased by 22.12% to $26.8 million in 2025, then declined by 12.02% to $23.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $23.6 million, $26.8 million, and $34.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 22.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.79 Mn |
| Mar 31, 2026 | 23.62 Mn |
| Dec 31, 2025 | 26.85 Mn |
| Sep 30, 2025 | 34.65 Mn |
| Jun 30, 2025 | 36.52 Mn |
| Mar 31, 2025 | 33.65 Mn |
| Dec 31, 2024 | 34.48 Mn |
| Sep 30, 2024 | 33.90 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 34.79 Mn |
| Dec 31, 2023 | 41.12 Mn |
| Sep 30, 2023 | 39.93 Mn |
| Jun 30, 2023 | 38.75 Mn |
| Mar 31, 2023 | 41.84 Mn |
| Dec 31, 2022 | 46.59 Mn |
| Sep 30, 2022 | 46.45 Mn |
| Jun 30, 2022 | 50.12 Mn |
| Mar 31, 2022 | 54.96 Mn |
| Dec 31, 2021 | 60.09 Mn |
| Sep 30, 2021 | 61.11 Mn |